Sarah Paraghamian, MD
Gynecologic Oncology · Boston, MANPI 1487066387
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,046 of the $3,177 with a category attached, or 64.4%. 15 manufacturers reported payments, led by Merck at 47.1% of the total. 2025 is the largest year on record at $1,827, more than ten times the $24 reported in 2019.
Across 34 payments — averaging $93.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$1K
- Karyopharm Therapeutics Inc.$983
- Intuitive Surgical$168
- EMD Serono, Inc.$133
- Caris MPI, Inc.$63
- Johnson & Johnson$62
- plus $271 from 9 others
Across 7 payments — averaging $10,296 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Karyopharm Therapeutics Inc.$39K
- AbbVie$33K
What the payments were for
- Travel & lodging$2,04664%
- Food & beverage$1,13036%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 9 | $1,497 |
| Karyopharm Therapeutics Inc. | 6 | $983 |
| Intuitive Surgical | 4 | $168 |
| EMD Serono, Inc. | 1 | $133 |
| Caris MPI, Inc. | 2 | $63 |
| Johnson & Johnson | 2 | $62 |
| Myriad Genetic Laboratories, Inc. | 2 | $56 |
| AstraZeneca | 1 | $46 |
| Genmab U.S., Inc. | 1 | $42 |
| Pfizer | 1 | $29 |
| Eisai Inc. | 1 | $25 |
| E.r. Squibb & Sons, L.L.C. | 1 | $24 |
| GSK | 1 | $19 |
| Urovant Sciences Inc | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XPOVIO$803
- Da Vinci Surgical System$135
How this compares
$3,177 in reported general payments places this provider in the 85th percentile of 32 gynecologic oncology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZejulaNiraparib Tosylate | 11 | $206,278 |
| LynparzaOlaparib | 15 | $128,113 |
| Letrozole | 12 | $312 |
| Clobetasol Propionate | 12 | $244 |
| Nystatin | 11 | $98 |
| Oxycodone Hcl | 18 | $52 |
| Ondansetron Hcl | 13 | $38 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKZejula | $19 | $206,27811 claims |
| AstraZenecaLynparza | $46 | $128,11315 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 32 gynecologic oncology providers in Massachusetts.
Other gynecologic oncology in Boston
- Amy BregarBoston$36K
- Whitfield GrowdonBoston$27K
- Alexander MelamedBoston$5K
- Michael MutoBoston$3K
- Taymaa MayBoston$2K
- Jessica St LaurentBoston$1K
- Leslie GarrettBoston$1K
- Jessica DisilvestroBoston$1K
- Young KimBoston$658
- Christopher AwtreyBoston$400
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.